 |
|
|
| |
Gender-related differences in safety after switching to BICTEGRAVIR/TAF/FTC in "real life"
|
| |
| |
EACS 2021 Oct 27-30
A. Moreno1, M. Velez2, M.J. Perez-Elias1, J.L. Casado1, A. Muriel3, M.J. Vivancos1, B. Montero2, J. Martinez1, S. Del Campo1, F. Dronda1, M. Rodriguez-Sagrado2, S. Moreno1
1Hospital Ramon y Cajal, Infectious Diseases, Madrid, Spain, 2Hospital Ramon y Cajal, Pharmacy, Madrid, Spain, 3Hospital Ramon y Cajal, Clinical Biostatistics, Madrid, Spain
|
| |
|
|
|
|
|
